Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

649 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 102
Recruiting: 49
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (104)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02061800	CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant	unknown	Phase 1 / Phase 2	14	Diane GeorgeOTHER	1	Jun 4, 2024	clinicaltrials
NCT04835584	KRT-232 and TKI Study in Chronic Myeloid Leukemia	unknown	Phase 1 / Phase 2	109	Kartos Therapeutics, Inc.INDUSTRY	8	Mar 21, 2022	clinicaltrials
NCT02885766